Review



hipsc lines  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC hipsc lines
    Tumor formation capacity of <t> 201B7 </t> hiPSCs in NOG mice.
    Hipsc Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 727 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/HY-R01034/pmc06171902-177-9-18?v=ATCC
    Average 96 stars, based on 727 article reviews
    hipsc lines - by Bioz Stars, 2026-08
    96/100 stars

    Images

    1) Product Images from "Tumorigenicity-associated characteristics of human iPS cell lines"

    Article Title: Tumorigenicity-associated characteristics of human iPS cell lines

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0205022

    Tumor formation capacity of 201B7 hiPSCs in NOG mice.
    Figure Legend Snippet: Tumor formation capacity of 201B7 hiPSCs in NOG mice.

    Techniques Used:

    Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subcutaneously transplanted into NOG mice at 3 × 10 4 cells with Matrigel and 1 × 10 6 mitomycin C-treated NHDF in the presence of 10 μM Y-27632. Tumor formation was examined for 16 weeks. Six mice were used in each group.
    Figure Legend Snippet: Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subcutaneously transplanted into NOG mice at 3 × 10 4 cells with Matrigel and 1 × 10 6 mitomycin C-treated NHDF in the presence of 10 μM Y-27632. Tumor formation was examined for 16 weeks. Six mice were used in each group.

    Techniques Used:

    Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subcutaneously transplanted into NOG mice at 3 × 10 4 cells with Matrigel and 1 × 10 6 mitomycin C-treated NHDF in the presence of 10 μM Y-27632. Tumor size was observed for 16 weeks. Six mice were used in each group.
    Figure Legend Snippet: Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subcutaneously transplanted into NOG mice at 3 × 10 4 cells with Matrigel and 1 × 10 6 mitomycin C-treated NHDF in the presence of 10 μM Y-27632. Tumor size was observed for 16 weeks. Six mice were used in each group.

    Techniques Used:

    Sizes and grades of tumor derived from hiPSCs transplanted into NOG mice.
    Figure Legend Snippet: Sizes and grades of tumor derived from hiPSCs transplanted into NOG mice.

    Techniques Used: Derivative Assay, Transplantation Assay

    In vitro cultured hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subjected to karyotype analysis. 454E2 and mc-iPS lines showed trisomy 12. Chromosomal aberrations are encircled.
    Figure Legend Snippet: In vitro cultured hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subjected to karyotype analysis. 454E2 and mc-iPS lines showed trisomy 12. Chromosomal aberrations are encircled.

    Techniques Used: In Vitro, Cell Culture

    Genes having mutations, which were assessed as a high or moderate impact and confirmed in the COSMIC cancer database.
    Figure Legend Snippet: Genes having mutations, which were assessed as a high or moderate impact and confirmed in the COSMIC cancer database.

    Techniques Used:



    Similar Products

    Image Search Results